Scientists develop and characterize variant-specific vaccine

In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.

Related Keywords

South Africa , United States , India , , Yale University , Coronavirus Disease Covid 19 , Cars , Ars Cov 2 , Ntibody , B Cell , Flood , D4 , Fell , Coronavirus , Ytometry , Efficacy , Flow Cytometry , Genes , Immune Response , Immunity , Immunization , Interferon , Interferon Gamma , Lymph Node , Anoparticle , Protein , Pseudovirus , Eceptor , Espiratory , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Spleen , Yndrome , Transcriptomics , Vaccine , Virus ,